The social restrictions amid coronavirus disease 2019 (COVID-19) pandemic have posed a serious threat to mental health and have implications in the use of medications for mental …
Few studies have delineated the real-world, long-term trends of prescription patterns of antidepressants for patients with major depressive disorder (MDD). This study aims to …
B Bang-Andersen, T Ruhland… - Journal of medicinal …, 2011 - ACS Publications
The synthesis and structure− activity relationship of a novel series of compounds with combined effects on 5-HT3A and 5-HT1A receptors and on the serotonin (5-HT) transporter …
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are popular medications for anxiety and depression, but their effectiveness, particularly in patients with prominent …
L Bartova, M Dold, A Kautzky, C Fabbri… - The World Journal of …, 2019 - Taylor & Francis
Objectives: The overview outlines two decades of research from the European Group for the Study of Resistant Depression (GSRD) that fundamentally impacted evidence-based …
V Abbing-Karahagopian, C Huerta… - European journal of …, 2014 - Springer
Purpose Drug utilization studies have applied different methods to various data types to describe medication use, which hampers comparisons across populations. The aim of this …
A Belloni, D Morgan, V Paris - 2016 - oecd-ilibrary.org
Across OECD countries, pharmaceutical spending reached around USD 800 billion in 2013, accounting for about 20% of total health spending on average when pharmaceutical …
Use of antidepressant medications that act on the serotonin system has been linked to detrimental impacts on bone mineral density (BMD), and to osteoporosis. This article …
MS Simon, G Arteaga-Henríquez… - Neuropsychiatric …, 2023 - Taylor & Francis
Purpose Immune imbalances in major depressive disorder (MDD) have been targeted by anti-inflammatory treatment approaches in clinical trials to increase responsiveness to …